Welcome to LookChem.com Sign In|Join Free
  • or
1-{2-[4-(7-methoxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl)phenoxy]ethyl}pyrrolidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

18196-29-7

Post Buying Request

18196-29-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

18196-29-7 Usage

Synonyms

GSK256073

Type

Synthetic pyrrolidine derivative

Pharmacological Activities

Not yet fully understood

Structure

Contains a pyrrolidine ring and a chromen-4-yl group

Molecular Structure

Suggests potential therapeutic applications

Research Status

Further research needed to understand biological effects and possible uses

Potential Applications

Therapeutic uses (pending further research)

Chemical Class

Organic compound

Functional Groups

Pyrrolidine ring, chromen-4-yl group, phenoxy group, and methoxy group

Check Digit Verification of cas no

The CAS Registry Mumber 18196-29-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,1,9 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 18196-29:
(7*1)+(6*8)+(5*1)+(4*9)+(3*6)+(2*2)+(1*9)=127
127 % 10 = 7
So 18196-29-7 is a valid CAS Registry Number.

18196-29-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[2-[4-(7-methoxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl)phenoxy]ethyl]pyrrolidine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:18196-29-7 SDS

18196-29-7Downstream Products

18196-29-7Relevant academic research and scientific papers

NOVEL (-)-ENANTIOMERS OF CIS-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES

-

, (2008/06/13)

The present invention relates to therapeutically active compounds of formula (I), a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related

Synthesis and pharmacological evaluation of novel cis-3,4-Diaryl-hydroxychromanes as high affinity partial agonists for the estrogen receptor

Bury, Paul S.,Christiansen, Lise B.,Jacobsen, Poul,Jorgensen, Anker S.,Kanstrup, Anders,Narum, Lars,Bain, Steven,Fledelius, Christian,Gissel, Birgitte,Hansen, Birgit S.,Korsgaard, Niels,Thorpe, Susan M.,Wassermann, Karsten

, p. 125 - 145 (2007/10/03)

The syntheses and in vitro pharmacological evaluation of a number of cis-3,4-diaryl-hydroxy-chromanes are reported, along with the results of a thorough in vivo profiling of the tissue-selective estrogen partial-agonist NNC 45-0781 [3, (-)-(3S,4R)-7-hydro

cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

-

, (2008/06/13)

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.

cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

-

, (2008/06/13)

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.

Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

-

, (2008/06/13)

The present invention relates to therapeutically active compounds of formula I STR1 a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen relat

(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes

-

, (2008/06/13)

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related di

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 18196-29-7